InsiderClue
Insiders · Profile

Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma. Filing since 28 Feb 2022. CIK 0001898490

Company
Date
Role
Action
Shares
Amount
Of holding
TBPH Theravance Biopharma, Inc.
15 Sep 2026
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
13,314
$226.79K
5.9%
TBPH Theravance Biopharma, Inc.
15 Jun 2026
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
13,314
$218.17K
5.4%
TBPH Theravance Biopharma, Inc.
16 Mar 2026
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
31,067
$433.64K
11.8%
TBPH Theravance Biopharma, Inc.
3 Dec 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
31,067
$582.50K
10.1%
TBPH Theravance Biopharma, Inc.
14 Jul 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
10,000
$113.87K
3.0%
TBPH Theravance Biopharma, Inc.
2 Jun 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
24,000
$264.00K
6.6%
TBPH Theravance Biopharma, Inc.
21 Apr 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
4,000
$36.00K
1.1%
TBPH Theravance Biopharma, Inc.
21 Jan 2025
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
4,000
$36.00K
1.3%
TBPH Theravance Biopharma, Inc.
11 Nov 2024
SVP, COMM & MEDICAL AFFAIRS
Sold at will
4,000
$36.00K
1.2%
TBPH Theravance Biopharma, Inc.
10 Jul 2024
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
4,000
$36.00K
1.2%
TBPH Theravance Biopharma, Inc.
22 Feb 2024
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
1,254
$10.92K
0.4%
TBPH Theravance Biopharma, Inc.
21 Nov 2023
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
1,378
$14.18K
0.4%
TBPH Theravance Biopharma, Inc.
22 Aug 2023
SVP, COMM & MEDICAL AFFAIRS
Sold on a plan
1,807
$17.11K
0.5%
TBPH Theravance Biopharma, Inc.
8 Jun 2023
SVP, COMM & MEDICAL AFFAIRS
Sold at will
1,790
$19.92K
0.5%
TBPH Theravance Biopharma, Inc.
9 Mar 2023
SVP, COMM & MEDICAL AFFAIRS
Sold, plan not stated
4,000
$40.80K
1.1%
TBPH Theravance Biopharma, Inc.
23 May 2022
SVP, COMM & MEDICAL AFFAIRS
Sold, plan not stated
1,081
$9.65K
0.3%
TBPH Theravance Biopharma, Inc.
28 Feb 2022
SVP, COMM & MEDICAL AFFAIRS
Sold, plan not stated
2,356
$23.95K
0.7%
17 decisions on file.